US IPO Pipeline SEC S-1 Filings — August 21, 2026
The IPO pipeline is active with 8 filings on August 21, 2026, spanning biotech, gaming, energy, and semiconductor sectors. The dominant theme is capital-intensive, pre-revenue or early-stage companies seeking public funding, with 5 of 8 filings being S-1 registrations for IPOs or follow-on offerings. A critical pattern is the prevalence of 'going concern' risks and heavy reliance on dilutive financing, particularly in the biotech space (Aptevo, Tempest, Alzamend). The largest transaction is ON Semiconductor's acquisition of Synaptics, a $4B+ deal that has seen the acquirer's stock price decline 30% since announcement, creating valuation uncertainty. Insider trading data is sparse, but capital allocation trends show a clear preference for equity financing over debt, with several companies using deep-discount convertible instruments (Alzamend) or at-the-market facilities (Tempest). The pipeline is characterized by high risk, high dilution, and speculative valuations, with few mature, profitable companies seeking public listing.